AliveDx seeks US FDA 510(k) premarket approval for MosaiQ AiPlex CD multiplex microarray: Eysins, Switzerland Tuesday, February 11, 2025, 12:00 Hrs [IST] AliveDx, an established c ...

Our CD microarray includes 5 markers in one panel for each patient, including the majority of autoantibodies recommended by the relevant clinical guidelines (ESsCD, ACG and ESPGHAN)* 2-5. The MosaiQ ...

The MammaPrint™ assay (Agendia BV, The Netherlands) is the first fully commercialized microarray-based multigene assay designed to individualize treatment for patients with breast cancer.

AliveDx’s CE mark for the systematic autoimmune rheumatic disease (SARD) assay marks its fifth approval in the past 18 months.

Figure 1. (Left) examples of flexible VaxArray microarray-based assay designs, with 5’CapQ assay schematic highlighted, (Center) a schematic of a single VaxArray microarray slide with 16 ...

3 Second, it is a common strategy that the identified DNA methylation sites and messenger RNAs (mRNAs) from microarray assays are validated using different technical methods (herein, bisulfate ...

Tissue microarrays (TMAs) have become ubiquitous ... Optimization of immunohistochemistry assays has typically been a subjective, manual process, which can be improved using objective and ...

On the other hand, no other organisms have such a well–developed EST database, a limitation, given that cDNA microarrays also permit the 'assay' of uncharacterized cDNAs (which may represent ...

Then, the microarrays were incubated with 10 μM P7C3-Bio or 10 μM ... free buffered DMEM for 1 h without CO2 immediately before the extracellular flux (XF) assay. The glycolytic rate assay was ...

However, one must consider that costs for quality control, validation, and registration of complex assays may increase costs considerably. Below, we have evaluated allergen microarrays based on ...